Thymidine-Dependent Staphylococcus aureus Small-Colony Variants Are Associated with Extensive Alterations in Regulator and Virulence Gene Expression Profiles by Kahl, Barbara C et al.
Dartmouth College 
Dartmouth Digital Commons 
Open Dartmouth: Published works by 
Dartmouth faculty Faculty Work 
7-2005 
Thymidine-Dependent Staphylococcus aureus Small-Colony 
Variants Are Associated with Extensive Alterations in Regulator 
and Virulence Gene Expression Profiles 
Barbara C. Kahl 
University of Muenster 
Gunnar Belling 
University of Muenster 
Petra Becker 
University of Muenster 
Indranil Chatterjee 
University of Saarland 
Katrin Wardecki 
University of Muenster 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.dartmouth.edu/facoa 
 Part of the Medical Immunology Commons, and the Medical Microbiology Commons 
Dartmouth Digital Commons Citation 
Kahl, Barbara C.; Belling, Gunnar; Becker, Petra; Chatterjee, Indranil; Wardecki, Katrin; Hilgert, Karin; and 
Cheung, Ambrose, "Thymidine-Dependent Staphylococcus aureus Small-Colony Variants Are Associated 
with Extensive Alterations in Regulator and Virulence Gene Expression Profiles" (2005). Open Dartmouth: 
Published works by Dartmouth faculty. 950. 
https://digitalcommons.dartmouth.edu/facoa/950 
This Article is brought to you for free and open access by the Faculty Work at Dartmouth Digital Commons. It has 
been accepted for inclusion in Open Dartmouth: Published works by Dartmouth faculty by an authorized 
administrator of Dartmouth Digital Commons. For more information, please contact 
dartmouthdigitalcommons@groups.dartmouth.edu. 
Authors 
Barbara C. Kahl, Gunnar Belling, Petra Becker, Indranil Chatterjee, Katrin Wardecki, Karin Hilgert, and 
Ambrose Cheung 
This article is available at Dartmouth Digital Commons: https://digitalcommons.dartmouth.edu/facoa/950 
INFECTION AND IMMUNITY, July 2005, p. 4119–4126 Vol. 73, No. 7
0019-9567/05/$08.000 doi:10.1128/IAI.73.7.4119–4126.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
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Chronic airway infection is a hallmark of cystic fibrosis (CF) and many CF patients are infected persistently
by Staphylococcus aureus. Thymidine-dependent trimethoprim-sulfamethoxazole (SXT)-resistant S. aureus
small-colony variants (SCVs), often in combination with isogenic normal S. aureus phenotypes, are highly
prevalent and persistent in airway secretions of CF patients due to long-term SXT therapy (B. Kahl, M.
Herrmann, A. S. Everding, H. G. Koch, K. Becker, E. Harms, R. A. Proctor, and G. Peters, J. Infect. Dis. 177:
1023–1029, 1998). In this report, SCVs were compared to normal S. aureus by transcription analysis of
important regulator (sigB, sarA, and agr) and virulence (-hemolysin, hla, and protein A, spa) genes. Growth
curve analyses revealed longer doubling times and lower final densities for SCVs than for normal strains. sigB
activity was measured by transcription analysis of the sigB target gene asp23. For nearly all SCVs, expression
of all regulators was decreased as assessed by asp23 reverse transcription-PCR for sigB and Northern analysis
for sarA and agr. These results are in agreement with diminished hla signals in all SCVs and increased spa
signals in 5 of 10 SCVs compared to the isogenic normal S. aureus. Both supplementation of SCVs with
thymidine and activation of the agr quorum-sensing system by the supernatant of the isogenic normal strain
reversed transcription to almost normal levels. In conclusion, multiple changes in growth characteristics and
in regulator and virulence gene expression render SCVs less virulent and allow them to survive in the hostile
environment present in the airways of CF patients, thereby illustrating adaptation of the bacteria during
long-term persistence.
Staphylococcus aureus is a major human pathogen responsi-
ble for a variety of community-acquired and nosocomial infec-
tions ranging from mild skin diseases, abscesses, and soft-tissue
diseases to life-threatening infections such as osteomyelitis,
endocarditis, pneumonia, and sepsis (19). Cystic fibrosis (CF)
is characterized by chronic suppurative airway disease with
progressive pulmonary insufficiency (16). Depending on the
study, 50 to 80% of children and adolescents with CF in par-
ticular are chronically colonized or infected by S. aureus (4, 5,
9, 13, 15, 23). However, the pathogenesis of persistent S. aureus
infection in CF patients is complex and not fully elucidated.
The persistence of S. aureus in CF and other persistent
infections such as osteomyelitis and device-related infections
has been associated with the isolation of S. aureus small-colony
variants (SCVs) (11, 15, 27). In contrast to the normal S. aureus
phenotype, SCVs grow as tiny, nonpigmented, and nonhemo-
lytic colonies. SCVs (i) produce greatly reduced amounts of
-hemolysin; (ii) persist within host cells in in vitro assays (26);
(iii) are auxotrophic for substrates such as menadione, hemin,
thiamine, or thymidine; and (iv) can revert to their normal
phenotype (1, 28). In a 6-year prospective study, persistence of
clonal SCVs and/or normal S. aureus has been shown in the
airways of CF patients over extended periods, as disclosed by
pulsed-field gel electrophoresis (15). From this study, 212
SCVs were available for auxotrophism testing. A total of 122
SCVs were thymidine dependent, and 26 SCVs were both
thymidine and hemin dependent. As a result of long-term
trimethoprim-sulfamethoxazole (SXT) treatment, SXT-resis-
tant and thymidine-dependent SCVs emerged, while the cor-
responding normal strains remained SXT susceptible (13).
While SXT interferes with the tetrahydrofolic acid pathway,
tetrahydrofolic acid acts as a coenzyme for thymidylate syn-
thetase, which catalyzes the synthesis of dTMP from dUMP
(25). Since dTMP is essential for DNA synthesis, susceptible S.
aureus strains are affected by SXT therapy. However, thymi-
dine-dependent SCVs are resistant to SXT and survive if ex-
tracellular thymidine is provided. Phenotypically, thymidine-
dependent SCVs display two different colony types, (i) fried-
egg SCVs with translucent edges surrounding a smaller,
elevated pigmented center and (ii) pinpoint colonies, which are
nearly 10 times smaller than the normal S. aureus colony (14).
S. aureus has the capability to synthesize a variety of extra-
cellular and cell wall-bound proteins, many of which are in-
volved in pathogenesis (22). The expression of most of these
virulence factors is under the control of global regulators such
as agr (accessory gene regulator) (17) and sarA (staphylococcal
accessory regulator) (7). The agr system of S. aureus represents
a quorum-sensing system. A secreted autoinducing peptide
(AIP) induces activation of the agr operon at a given threshold,
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thereby up-regulating extracellular protein production while
down-regulating synthesis of cell wall-associated proteins,
which serve as adhesins for the pathogen to host tissues (17).
The sarA locus encodes the DNA binding protein SarA, which
activates the synthesis of both extracellular and cell wall-asso-
ciated proteins via agr-dependent and agr-independent path-
ways (8). The sarA locus is composed of three overlapping
transcripts with sarA P1 (0.58 kb) and sarA P2 (1.15 kb) max-
imally transcribed during the exponential phase (tapering to-
ward the stationary phase), while sarA P3 (0.84 kb) is expressed
primarily during the late-exponential and stationary phases (2).
Based on transcriptional analysis, the sarA P3 promoter has
been shown to be sigB dependent (10, 20). In contrast to the
primary sigma factor SigA, which is responsible for the tran-
scription of housekeeping genes, the alternative sigma factor
SigB (sigB) plays an important role in regulating gene expres-
sion upon environmental stresses (e.g., stationary phase, heat,
and osmotic stresses).
While the phenotypic characteristics of clinical and labora-
tory SCVs have been described by several groups (21, 28, 29),
a detailed analysis of alteration in gene regulation putatively
contributing to or resulting in the SCV phenotype has not been
attempted. Therefore, in this report, we characterized the tran-
scription patterns of important regulator (sigB, sarA, and agr)
and virulence genes (hla and spa) of long-term persisting thy-
midine-dependent S. aureus SCVs isolated from the airways of
CF patients in comparison to the normal isogenic strain, which
was isolated at the same time.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Ten normal and S. aureus SCV strain
pairs previously described were used for further analysis (15). These strain pairs
were cultured from individual CF patients persistently infected by S. aureus. All
SCVs were thymidine dependent and clonal to their normal counterpart, as
determined by pulsed-field gel electrophoresis as described previously (13). To
ensure stability of the SCV phenotype, the first four strain pairs were subcultured
at least 10 times in the laboratory. To confirm the transcription patterns of these
pairs, which have been repetitively subcultured in the laboratory, six other iso-
genic thymidine-dependent SCV-normal strain pairs from other patients were
chosen for further analysis. These strain pairs were subcultured only once after
primary storage at 70°C. Five SCVs displayed the fried-egg phenotype with
translucent edges surrounding a smaller, elevated pigmented center; the other
five SCVs exhibited pinpoint colonies, which are nearly 10 times smaller than the
normal S. aureus colony size.
Normal S. aureus isolates and SCVs were grown in brain heart infusion (BHI;
Merck, Darmstadt, Germany) broth, which supports the growth of SCVs, while
Escherichia coli was grown in Luria-Bertani broth. E. coli InvF (Invitrogen,
Karlsruhe, Germany) was used as a host strain for the TA cloning vectors pCRII
and pCR 2.1. For the growth curve analysis, cultures were grown at 35°C on a
rotary shaker. For the determination of the optical density at 578 nm (OD578)
beyond a value of 2, the value of the ODs was calculated from readings of diluted
cultures. Ampicillin was used at a concentration of 50 g/ml. For supplementa-
tion studies, thymidine (Fluka Chemie, Buchs, Switzerland) was added to BHI
broth at a concentration of 100 g/ml.
DNA probes. The internal fragments of the following genes were amplified by
PCR (Perkin Elmer 2400, Überlingen, Germany): sarA, nucleotides (nt) 864 to
1218 (GenBank accession no. U46541) RNAIII, nt 1260 to 1571 (GenBank
accession no. X52543); hla, nt 583 to 1211 (GenBank accession no. X01645); and
spa, nt 776 to 1160 (GenBank accession no. X61307). PCR products were cloned
into pCRII or pCR 2.1 (Invitrogen), sequenced for control with the ABI PRISM
310 Genetic Analyser (Perkin Elmer, Weiterstadt, Germany), and used as
probes, which were generated by the Dig Probe Synthesis kit (Roche, Mannheim,
Germany), for Northern blot analysis. Plasmid DNA was extracted with the
QIAprep Spin Mini Kit (QIAGEN, Hilden, Germany).
Isolation of RNA and Northern analysis. Prior to RNA extraction, growth
curves were performed for normal isolates, SCVs, and SCVs supplemented with
thymidine. RNA was extracted according to early log, late log, and stationary
phases for the particular strains. Overnight cultures of normal colonies and S.
aureus SCVs were set to 0.1 at an optical density at 578 nm (OD578) in BHI and
were then allowed to grow to the respective growth phases. For supplementation
of SCVs, 100 g/ml thymidine was added to the BHI broth.
The cells were pelleted, and total cellular RNA was isolated with the FastPrep
system (Fast Prep FP120 instrument; Qbiogene, Heidelberg, Germany) (2).
Since SCVs have a tendency to revert to normal growth, the growth of SCVs after
the shaking liquid culture was controlled by streaking the respective cultures
onto Columbia blood agar plates, which were incubated for 24 h at 35°C. The
extracted RNA was processed further only if the SCVs did not revert to the
normal phenotype or if 30% of the cultures reverted. Ten micrograms of RNA
was electrophoresed through a 1.5% 0.66 M formaldehyde gel in morpholinepro-
panesulfonic acid (MOPS) running buffer (20 mM MOPS, 10 mM sodium ace-
tate, 2 mM EDTA [pH 7.0]). Every gel was controlled for equal loading of RNA.
RNA was transferred onto a Hybond N membrane (Amersham Pharmacia
Biotech Europe GmbH, Braunschweig, Germany) under mild alkaline condi-
tions with a turboblotter system (Schleicher and Schuell, Dassel, Germany).
RNA was fixed to the membrane by baking (80°C for 0.5 h), hybridized under
aqueous conditions at 65°C overnight with the digoxigenin-labeled DNA probes,
washed, and detected by chemiluminescence (Roche, Mannheim, Germany).
One fried-egg SCV and one pinpoint SCV with their respectie isogenic normal
strains were chosen for optimal representation and reproducibility of the tran-
scription patterns of the different tested strain pairs.
asp23 transcription by reverse transcription-PCR. For RNA isolation from
culture, S. aureus was grown in BHI medium to the desired growth phase and
controlled for potential reversion of the phenotype as described above. Bacteria
were mechanically disrupted (Fast Prep FP120 instrument; Qbiogene, Heidel-
berg, Germany), and RNA was isolated (RNeasy mini kit; QIAGEN, Hilden,
Germany). After treatment with RNase-free DNase I (QIAGEN), total RNA
samples were amplified in an ABI PRISM 7000 SDS with SYBR Green PCR
Master Mix (Applied Biosystems, Weiterstadt, Germany) and gyrB primers (gyrB
f1, 5-GACTGATGCCGATGTGGA-3; gyrB r1, 5-AACGGTGGCTGTGCA
ATA-3) to check for the absence of genomic DNA. Previously transcribed
cDNA served as a positive control. RNA was then reverse transcribed (High
Capacity cDNA Archive kit; Applied Biosystems). cDNA was used for real-time
amplification with asp23-specific primers (asp23 fl, 5-CAAGAACAAAATCAA
GAGCCTCAAT-3; asp23 r1, 5-CTTCACGTGCAGCGATACCA-3) and 100
ng of cDNA per reaction mixture. The level of mRNA expression of asp23 was
normalized against the internal control gyrB expression, which is constitutively
expressed (12). The amount of asp23 transcript was expressed as the n-fold
expression difference of asp23 relative to the expression of the control gene gyrB
(2CT, where CT represents the difference in threshold cycle between the
target and control genes). All determinations were performed in duplicate.
agr activation of S. aureus SCVs by the isogenic normal S. aureus. For the
activation of SCVs by the AIP of the isogenic normal strain, the culture super-
natant (SN) from the normal strain was prepared after overnight culture and
sterile filtration. Bacteria were inoculated from an overnight culture to an initial
OD578 of 0.1 in BHI and grown for 1 h at 35°C. One-tenth of the sterile SN or
1/10 of BHI (as a control) was added to 9/10 of the culture, after which the
bacteria were allowed to grow for another 2 h or 4 h. RNA was prepared as
described above. The activity of agr was assessed by Northern blot analysis with
an RNAIII probe as described above.
RESULTS
SCVs have an extended lag phase and do not reach the
densities of normal strains. For each normal colony/SCV
strain pair, growth curves were analyzed. Five of the tested
SCVs belonged to the fried-egg phenotype, while the other five
SCVs exhibited pinpoint colonies (Table 1). All SCVs differed
in their growth phase characteristics from normal strains (Fig.
1A and 2A) by extended lag phases (mean difference from the
normal S. aureus colony, 2.85 h; range, 1 to 6 h) and lower final
densities (mean OD at 578 nm [OD578], 4.5; range, 2 to 8
compared to a mean OD578 of 12.3; range, 9 to 14 for the
normal S. aureus colony) (Table 1). The maximum densities for
pinpoint SCVs were even lower than for fried-egg SCVs (Table
1; Fig. 1A and 2A). If SCVs were supplemented with thymi-
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dine, the bacteria yielded higher densities than nonsupple-
mented SCVs. There was a difference in growth after supple-
mentation between the fried-egg and pinpoint phenotypes.
While the maximum density of most fried-egg SCVs was
reached within 12 h (four of five SCVs) upon supplementa-
tion with thymidine, the maximum optical density of all pin-
point SCVs (five of five) was not reached within this period and
was determined for two pinpoint SCVs at 19 h, as shown in Fig.
2A for one particular pinpoint SCV.
Expression of sigB, sarA, and agr is decreased in SCVs. As
SigB represents an alternate sigma factor, which reacts to en-
vironmental stress especially in response to growth phase, heat
shock, or starvation, we evaluated transcription of this impor-
tant regulator. Since the activity of SigB is determined by the
amount of free SigB dissociated from its anti-sigma factor
RsbW, SigB activity is best determined by expression of asp23,
a SigB target gene (3). asp23 transcription was expressed as
fold increase compared to the expression of the constitutively
transcribed gyrB gene. The expression of asp23 was decreased
in eight of nine SCVs tested, compared to isogenic normal strains
(Table 1). Only SCV 2 expressed nearly the same levels of asp23
as the normal strain. Interestingly, there was a high rate of vari-
ation of asp23 activity among the different normal strains, ranging
from 1.5- to 178-fold increase over gyrB gene expression during
the stationary phase of normal strains. Since sigB activity is im-
portant for the pigmentation of S. aureus, we determined the
color of the strains grown on Columbia blood agar plates (Table
1). Seven of 10 SCVs displayed fewer pigmented colonies than the
normal strains. These differences in pigmentation between nor-
mal and SCVs were consistent with low levels of asp23 in SCVs.
However, normal strain 9, which had the highest activity of asp23,
displayed white colonies on the agar plate, indicating that addi-
tional factors also have an impact on pigmentation (Table 1). The
asp23 activity of nine SCVs was additionally tested by supple-
menting the medium with 100 g/ml of thymidine. Five of these
SCVs were fully restored and three were partially restored in their
asp23 activity, while only one SCV was not supplemented (data
not shown).
TABLE 1. Results of growth and transcriptional analysis of 10 thymidine-dependent SCV-normal S. aureus strain pairs isolated from airway









RNAIII sarA P3 hla spa asp23
el ll sp el ll sp el ll sp el ll sp el ll sp
1 Normal 9  Yf      / /      1.3 2.7 8.0
SCV FEg 5  Wh       /      1.0 0.8 0.6
2 Normal 12  Y /            2.7 9.9 18.9
SCV FE 5 / W             1.1 NDj 23.9
3 Normal 13  Y             ND
SCV PPi 3  W / / /  /        ND
4 Normal 14 / W /            1.0 7.0 6.7
SCV PP 2 / W             0.6 2.4 2.6
5 Normal 12  Y             0.2 5.0 1.5
SCV FE 8  W /  / / / /  / /    0.1 0.4 0.7
6 Normal 14  Y  / /          3.6 67.2 43.3
SCV FE 6 / W  / /   /      / 1 0.8 1.7
7 Normal 11  Y           /  1.0 4.3 3.5
SCV PP 6 / W  ND /  ND   ND   ND  2.0 1.8 0.5
8 Normal 14  W  /          1.5 12.1 16.6
SCV FE 6  W      / / / /    0.9 2.7 1.4
9 Normal 12  W             8 129.8 178
SCV PP 2  W             18.9 99.9 35
10 Normal 12  Y    /         3.2 11.9 3.7
SCV PP 2  W    / /  / /     0.5 1.9 1.4
a Maximum OD578 during growth curve analysis.
b Hemolysis on Columbia blood agar (sheep blood). Hemolysis was determined as follows: , none; /, weak; , median; , strong.
c Pigmentation of S. aureus colonies on Columbia blood agar.
d Northern analysis of RNA extracted at early log (el), late log (ll) and stationary phase (sp). Blots were probed with digoxigenin-labeled gene probes for RNAIII,
sarA, hla, and spa. Signals were detected by chemiluminescence and characterized as follows: , none; /, weak; , median; , strong; , very strong.
e Fold increase of asp23 over the constitutively expressed gyrase.
f Y, yellow pigment of S. aureus on Columbia blood agar.
g FE, SCV with fried-egg appearance.
h W, white pigment of S. aureus on Columbia blood agar.
i PP, SCV with pinpoint appearance.
j ND, not done.
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To assess the activity of the sarA regulon in SCVs versus
normal strains, we analyzed sarA transcription by Northern
blot analysis. The normal clinical strains displayed quite typical
sarA transcription patterns: sarA P1 and sarA P2 were maxi-
mally expressed during early log phase, declining towards sta-
tionary phase, while sarA P3 was most active during stationary
phase (Fig. 1B and 2B). sarA P3 expression of the SCVs was
not detectable or maximal during stationary phase and always
decreased compared to the level of the normal S. aureus (Fig.
1B and 2B) in 9 of 10 SCVs tested (Table 1). Only SCV 4
FIG. 1. Growth phase analysis and transcription profiles of a normal S. aureus strain, the isogenic thymidine-dependent SCV with fried-egg
appearance, and the SCV supplemented with thymidine. (A) For growth phase analysis (strain pair 1), bacteria were cultured in BHI or BHI
supplemented with 100 g/ml thymidine on a rotary shaker at 37°C. Every hour, bacteria were harvested and the optical density at 578 nm was
determined. (B) Transcription analysis of sarA, RNAIII, hla, and spa of the normal S. aureus strain 5, its isogenic thymidine-dependent SCV with
fried-egg appearance, and the SCV supplemented with 100 g/ml thymidine, representative for typical transcription patterns as found in other
SCV-normal strain pairs with fried-egg appearances. RNA was harvested at early log phase (EL), late log phase (LL), and stationary phase (SP).
Ten micrograms of total RNA was applied to each lane.
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displayed the same sarA P3 transcription level as the normal S.
aureus (Table 1). The differential effect of SCVs and normal S.
aureus phenotypes was less apparent on sarA P1 and sarA P2
transcription. Upon supplementation with thymidine, tran-
scription for sarA P3 was partially restored in two of seven
SCVs and fully restored in five of seven SCVs (Fig. 1B and 2B).
To determine the activity of the agr regulon, which is partly
dependent on sarA activity, we consecutively used an RNAIII
probe for Northern analysis. While agr transcription was high-
est in late exponential and stationary phases in normal S.
aureus strains, agr transcription was absent or decreased in
eight of nine SCVs (Fig. 1B and 2B). SCV 6 displayed a
stronger RNAIII transcript than the normal strain 6, whereas
no RNAIII transcript was detectable for either phenotype of
strain pair 1 (Table 1). In four of seven SCVs supplemented
with thymidine, RNAIII transcription was fully restored, as
FIG. 2. Growth phase analysis and transcription profiles of a normal S. aureus strain, the isogenic thymidine-dependent SCV with pinpoint
phenotype, and the SCV supplemented with thymidine (strain pair 10). (A) For growth phase analysis, bacteria were cultured in BHI or BHI
supplemented with 100 g/ml thymidine on a rotary shaker at 37°C. Every hour, bacteria were harvested and the optical density was determined
at 578 nm. (B) Transcription analysis of sarA, RNAIII, hla, and spa of a normal S. aureus strain, the isogenic thymidine-dependent SCV with
pinpoint phenotype, and the SCV supplemented with 100 g/ml thymidine, representative for typical transcription patterns as found in other
pinpoint SCV-normal strain pairs. RNA was harvested at early log, late-log, and stationary phases. Ten micrograms of total RNA was applied to
each lane.
VOL. 73, 2005 THYMIDINE-DEPENDENT S. AUREUS SCVs 4123
shown in the representative strain pairs (Fig. 1B and 2B) and
partially restored in SCV 2 (data not shown). Upon thymidine
supplementation of SCV 6, which displayed a higher level of
RNAIII transcript than the normal S. aureus, the RNAIII
transcript was highly expressed during all growth phases (data
not shown).
-Hemolysin and protein A transcription are altered in
SCVs compared to normal S. aureus. The presence and tran-
scription of sarA- and agr-dependent virulence genes such as
hla and spa were analyzed. Despite the presence of the -he-
molysin gene (hla) in all studied SCVs and normal strains as
determined by Southern blot analysis (data not shown), tran-
scription of hla was found to be significantly lower in all SCVs
than in the normal cohort strains (Table 1; Fig. 1B and 2B). As
anticipated, transcription of hla was maximal in late logarith-
mic and stationary phases in normal strains, while transcription
of hla was decreased or almost absent in all SCVs (Fig. 1B and
2B; Table 1). Upon supplementation with thymidine, hla ex-
pression was fully restored in all SCVs (Fig. 1B and 2B).
Southern blot analysis disclosed the presence of spa in all
strains (data not shown). In exponential growth phase, tran-
scription of spa in SCVs was comparable to the normal strains
(Fig. 1B and 2B). spa transcription of the normal strains de-
clined towards late log phase, and no spa signal was detectable
during stationary phase. In contrast, spa signals of many SCVs
increased toward late log phase and were still present or even
increased during stationary phase in five of nine SCVs (Fig. 1B
and 2B). In SCVs 6 and 8, spa signals were weaker than in the
normal strains, while in SCVs 1 and 2 no difference in spa
transcription between the SCV and normal phenotype was
apparent (Table 1). Strain pair 3 did not express spa (Table 1).
The transcription results concerning spa in SCV and normal
strain pairs were consistent with the expression of Spa, as
determined by Western blot analysis after extraction of cell
wall-associated proteins, which were probed with chicken anti-
protein A antibodies (data not shown). Upon supplementation
with thymidine, transcription of spa was fully restored for
SCVs 5 and 10 (Fig. 1B and 2B) and partially restored for SCV
7 (data not shown). No difference in transcription was seen in
SCVs 1, 2, and 8. In strain pair 6 with the enhanced spa signal
in the normal strain, the thymidine-supplemented SCV ex-
pressed spa only during the early log phase, while the SCV
expressed spa at all time points.
agr activation of an SCV by the AIP of the normal S. aureus
strain. At a certain threshold, S. aureus secretes an AIP growth
phase dependently into the medium to communicate and syn-
chronize the expression of virulence genes. During growth
phases, SCVs reached only low cell densities. Therefore, we
hypothesized that the threshold for the activation of the agr
regulon may not be reached in SCVs. Accordingly, we analyzed
whether the AIP of the normal strain is able to activate the agr
response of SCVs. To test this, the SN of an isogenic normal S.
aureus was prepared after overnight culture and added to an early
growth phase culture of normal and S. aureus SCVs, which were
further grown in the presence or absence of the AIP. The activity
of agr was determined by Northern blot analysis. While no
RNAIII signal was detected after 2 h or 4 h in the SCV grown in
BHI only, the addition of the AIP of the normal strain activated
the agr response of the SCV strain at 2 h and 4 h (Fig. 3),
indicating a potentially functional agr locus.
DISCUSSION
Thymidine-dependent SCVs are highly prevalent and per-
sistent in airway secretions of CF patients if the patients are
treated or have been treated by long-term SXT (11, 13, 15). In
this report, we demonstrated profound alterations of growth
characteristics and regulator and effector gene expression in
clinical thymidine-dependent SCVs compared to their isogenic
normal S. aureus strains isolated at the same time. Both fried-
egg and pinpoint SCV phenotypes displayed slower growth
curves than the isogenic normal S. aureus strains. Interestingly,
the two phenotypes of SCVs could be distinguished not only by
their different morphotypes but also by their growth charac-
teristics, because pinpoint SCVs had even longer doubling
times and reached much lower densities than the fried-egg
SCVs. Additionally, differences between these phenotypes
were also obvious upon supplementation with thymidine, since
the growth curves of most fried-egg SCVs reverted earlier to
the growth characteristics of a normal phenotype upon supple-
mentation than the pinpoint SCVs, probably due to faster
growth and earlier uptake of external thymidine. However,
transcription profiles of both phenotypes were comparable,
depending on the respective background of the normal strain.
The alternative sigma factor SigB represents a powerful reg-
ulatory effector in response to environmental stress (18). Using
asp23 transcription as a marker for sigB activity, we assessed
sigB activity of SCVs versus isogenic normal S. aureus strains.
Since environmental changes such as long-term antibiotic ther-
apy have resulted in the SCV phenotype, we expected an in-
creased stress response in SCVs. In contrast to our expecta-
tions, the expression of sigB was decreased compared to the
normal S. aureus strains, probably due to the action of other
upstream-located regulators or as an indication that limited
sources of thymidine, which are crucial for the survival of
thymidine-dependent SCVs, are not sensed by sigB. Low levels
of sigB expression were consistent with the nonpigmentation of
SCVs in comparison to the normal S. aureus. The sarA P3
promoter has been shown to be under the control of sigB (2,
10, 20). The regulatory network of the sigB-sarA-agr regulators
is very complex. While Chien et al. have shown that functional
SarA controls agr expression (8), Bischoff et al. demonstrated
that sigB increases sarA expression while RNAIII levels were
FIG. 3. agr activation of SCV strains by the AIP of the isogenic
normal S. aureus strain. To determine if the agr regulon of SCVs can
be activated by the AIP of the isogenic normal S. aureus, the super-
natant of the normal strain was prepared after overnight culture and
added to SCV and to normal growth cultures at the indicated time
points. As a control, BHI broth alone was added to SCV and normal
cultures.
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reduced simultaneously (3). The data of these two groups
indicate that sigB has sarA-dependent as well as sarA-indepen-
dent effects upon agr transcription. Our data are consistent in
view of the sigB-sarA hierarchy resulting in a decreased level of
sarA P3 transcription, presumably due to low sigB activity in
SCVs compared to the normal S. aureus strains, as shown for
9 of 10 SCVs. Furthermore, low levels of agr transcription in
SCVs are consistent with low levels of sarA P3 expression.
Bischoff et al. demonstrated that low sigB transcription re-
sulted in up-regulation of agr. However, agr transcription in
SCVs was almost absent, indicating sigB-independent regula-
tion of agr in SCVs.
The fact that thymidine supplementation of SCV 6 resulted
in enhanced RNAIII transcription compared to the very weak
RNAIII transcript present in the respective isogenic normal
strain, which was isolated at the same time, suggests that this
SCV emerged earlier from an isogenic normal strain, which
presumably displayed strong agr activity. Interestingly, the iso-
genic normal strain, which was isolated at the same time as the
SCV, apparently underwent changes of the agr regulon during
long-term persistence, resulting in an almost negative agr sta-
tus. Changes in the agr regulon have been shown to occur
during serial passages in vitro, due to mutations in the nucle-
otide sequence of agr (24). It is conceivable that such changes
also occur due to long-term persistence of S. aureus in the host.
The assumptions that the SCV emerged from an earlier nor-
mal strain with an active agr regulon are also consistent con-
cerning the spa transcription, because after supplementation of
the SCV, the spa transcript was strongest during the early log
phase and not present in the later growth phases (in contrast to
the spa transcript of the isogenic normal strain isolated at the
same time, which also expressed a strong signal during station-
ary phase).
As with SCVs associated with hemin and/or menadione aux-
otrophy (1, 28), thymidine-dependent SCVs do not readily
produce -hemolysin on Columbia agar (14). Although hla was
present in SCVs as confirmed by Southern blotting, the expres-
sion of hla was strongly down-regulated in SCVs at the tran-
scriptional level. These results are not surprising, considering
the decrease in sarA activity, as well as in agr activity, which
concertedly controls hla expression. Although it has been
shown that sigB affects hla transcription, resulting in increased
hemolysis in a sigB mutant strain, low levels of sigB activity in
SCVs were not associated with a hemolytic phenotype (6),
indicating sigB-independent regulation of hla in these SCVs.
Taken together, thymidine-dependent SCVs display an agr
mutant phenotype in light of an inactive agr locus (RNAIII)
associated with increased spa transcription and decreased hla
transcription. Interestingly, upon thymidine supplementation
of SCVs, transcription of the agr locus and the agr-dependent
virulence genes spa and hla were fully or partially restored in
most SCVs, confirming that the agr locus was potentially func-
tional in SCVs. Moreover, it was possible to activate the agr
response of SCVs by the AIP of the isogenic normal S. aureus
strain, suggesting that the agr system was inactive, probably due
to the decreased growth rate and low density of AIP present in
SCVs. The fact that sigB and sarA expression, which is inde-
pendent of agr, was also restored after thymidine supplemen-
tation points to other regulatory mechanisms responsible for
the various alterations that occur in thymidine-dependent
SCVs.
In conclusion, multiple changes in growth characteristics and
in regulator and virulence gene expression render SCVs less
virulent and allow them to survive in the hostile environment
present in the airways of CF patients, thereby illustrating ad-
aptation of the bacteria during long-term persistence.
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